WHO ICTRP trial
CORAL XT – OPEN-LABEL EXTENSION TRIAL OF THE CORAL TRIAL
PER-003-14 · Registro Peruano de Ensayos Clínicos (REPEC)
Key facts
| Trial ID | PER-003-14 |
|---|---|
| Public title | CORAL XT – OPEN-LABEL EXTENSION TRIAL OF THE CORAL TRIAL |
| Scientific title | AN OPEN-LABEL, MULTI-SITE TRIAL TO DESCRIBE THE SAFETY AND TOLERABILITY OF ORAL CEBRANOPADOL ADMINISTERED FOR 26 WEEKS IN SUBJECTS WITH CANCER-RELATED PAIN WHO HAVE COMPLETED TREATMENT IN THE KF6005/07 TRIAL. |
| Primary sponsor | GRUNENTHAL GmbH, |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Study type | Interventional |
| Phase | III |
| Countries | Germany;Austria;Belgium;Bulgaria;Croatia;Denmark;Slovakia;Spain;France;Hungary;Poland;United Kindgdom;Romania;Sweden;New Zealand;Serbia;Argentina;Brazil;Chile;Mexico;Peru |
| Conditions | -D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites Neoplasm of uncertain or unknown behaviour of other and unspecified sites;D48 ;Neoplasm of uncertain or unknown behaviour of other and unspecified sites |
| Interventions | Subjects will receive cebranopadol and the dose will be up- or down-titrated to reach the individual subjects’ optimal dose defined as a balance between self-reported analgesia and side effects during the approximately 2-week Titration… |
| Registration date | Jun 27, 2014 |
| Target size | 22 |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: